论文部分内容阅读
在并不久远的将来,会不会有一批在美国市场上大行其道的生物技术公司,当人们关注其公司结构时发现,它们的研发甚至生产等“后院部门”不是在美国本土,而是在遥远的中国大陆?
In the near future, there will be a group of biotech companies that are popular in the U.S. market. When people pay attention to their corporate structure, they discover that their R&D and even production “backyard departments” are not in the U.S. but In the distant mainland China?